Emilie Vazeille1, Anthony Buisson1, Marie-Agnès Bringer2, Marion Goutte1, Lemlih Ouchchane3, Jean-Pierre Hugot4, Amélie de Vallée2, Nicolas Barnich2, Gilles Bommelaer1, Arlette Darfeuille-Michaud1. 1. Clermont Université, UMR 1071 Inserm/Université d'Auvergne, Clermont-Ferrand, France Department of Hepato-Gastroenterology, University Hospital Estaing of Clermont-Ferrand, Université d'Auvergne, Clermont-Ferrand, France. 2. Clermont Université, UMR 1071 Inserm/Université d'Auvergne, Clermont-Ferrand, France. 3. Université Clermont 1, CHU Clermont-Ferrand, Pôle Santé PubliqueCentre Nationale de la Recherche en Santé, Institut de l'image pour les Sciences Interventionnelles Techniques, UMR6284 Clermont-Ferrand France. 4. UMR843, INSERM, Assistance Publique Hôpitaux de Paris et Université, Paris Diderot, France.
Abstract
BACKGROUND: Ileal lesions of Crohn's disease [CD] patients are colonised by adherent-invasive Escherichia coli [AIEC] able to survive in macrophage cell lines. We analysed the ability of monocyte-derived macrophages [MDM] from CD patients to control AIEC intracellular replication and the pro-inflammatory cytokine response of the infected-MDM. METHODS: Peripheral blood MDM were obtained from 24 CD genotyped for NOD2 and ATG16L1 mutations, 5 ulcerative colitis [UC] patients and 12 healthy controls [HC]. The numbers of intracellular bacteria were determined using gentamicin assay. Cytokine secretion was quantified by ELISA assay. RESULTS: We observed that higher levels of bacteria were internalised within MDM from CD patients than MDM from HC or UC patients. MDM from CD patients were unable to restrict AIEC intracellular replication. Infection of MDM from CD patients with AIEC resulted in significantly increased secretion of IL-6 and tumour necrosis factor alpha [TNF α] than did infection with non-pathogenic E. coli. AIEC-infected MDM from CD patients exhibited a disordered cytokines secretion compared with MDM from UC patients and HC. AIEC-infected MDM from patients with quiescent CD released significantly higher amounts of IL-6 and TNF-alpha than those with active disease or those from HC. The level of secreted TNF-alpha was correlated to the number of intracellular AIEC in MDM from CD patients. Treatment of MDM with infliximab did not change the MDM behaviour. CONCLUSIONS: MDM from CD patients are unable to restrict intracellular AIEC replication, leading to disordered inflammatory response influenced by disease activity.
BACKGROUND: Ileal lesions of Crohn's disease [CD] patients are colonised by adherent-invasive Escherichia coli [AIEC] able to survive in macrophage cell lines. We analysed the ability of monocyte-derived macrophages [MDM] from CDpatients to control AIEC intracellular replication and the pro-inflammatory cytokine response of the infected-MDM. METHODS: Peripheral blood MDM were obtained from 24 CD genotyped for NOD2 and ATG16L1 mutations, 5 ulcerative colitis [UC] patients and 12 healthy controls [HC]. The numbers of intracellular bacteria were determined using gentamicin assay. Cytokine secretion was quantified by ELISA assay. RESULTS: We observed that higher levels of bacteria were internalised within MDM from CDpatients than MDM from HC or UC patients. MDM from CDpatients were unable to restrict AIEC intracellular replication. Infection of MDM from CDpatients with AIEC resulted in significantly increased secretion of IL-6 and tumour necrosis factor alpha [TNF α] than did infection with non-pathogenic E. coli. AIEC-infected MDM from CDpatients exhibited a disordered cytokines secretion compared with MDM from UC patients and HC. AIEC-infected MDM from patients with quiescent CD released significantly higher amounts of IL-6 and TNF-alpha than those with active disease or those from HC. The level of secreted TNF-alpha was correlated to the number of intracellular AIEC in MDM from CDpatients. Treatment of MDM with infliximab did not change the MDM behaviour. CONCLUSIONS:MDM from CDpatients are unable to restrict intracellular AIEC replication, leading to disordered inflammatory response influenced by disease activity.
Authors: Artur Dembiński; Zygmunt Warzecha; Piotr Ceranowicz; Marcin Dembiński; Jakub Cieszkowski; Tomasz Gosiewski; Małgorzata Bulanda; Beata Kuśnierz-Cabala; Krystyna Gałązka; Peter Christopher Konturek Journal: Gastroenterol Res Pract Date: 2016-06-28 Impact factor: 2.260
Authors: Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm Journal: Clin Transl Immunology Date: 2016-12-16
Authors: Lina Y Alkaissi; Martin E Winberg; Stéphanie D S Heil; Staffan Haapaniemi; Pär Myrelid; Eduard F Stange; Johan D Söderholm; Åsa V Keita Journal: Inflamm Bowel Dis Date: 2021-06-15 Impact factor: 5.325